Fundacion Para la Investigacion Medica Aplicada Fima

Fundacion Para la Investigacion Medica Aplicada Fima is a research organisation in Pamplona, Spain that has taken part in 45 EU-funded projects since 2008, receiving €19.8M in EU funding and leading 22 as coordinator.

EU funding received€19.8M
EU projects45
As coordinator22
Running now6
First EU project2008
Latest project2026
CountrySpain
EU registration (PIC)999485382
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fundacion Para la Investigacion Medica Aplicada Fima's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€8.2M · 24 projects
  • Horizon Europe€6.0M · 9 projects
  • Horizon 2020€5.6M · 12 projects

Projects

45 EU-funded projects, newest first. Fundacion Para la Investigacion Medica Aplicada Fima led 22 of them as coordinator. Each links to the official record.

  • LINCURECoordinator

    Harness lncRNA targeting to treat colorectal cancer

    Horizon Europe · 2026–2027 · Project on CORDIS ↗

    €110ktheir share
  • RENALGENECoordinator

    Advancing genetic medicines for inherited kidney disease

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €1.5Mtheir share
  • NeuroNanotechPartner

    Nanoplatforms for Neuroscience

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €252ktheir share
  • RIPECROPCoordinator

    RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.4Mtheir share
  • SPACETIMEPartner

    SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €620ktheir share
  • TLSaRNACoordinator

    Artificial induction of tertiary lymphoid structures (TLS) in tumors using intratumoral mRNAs to evaluate its synergy with immune checkpoint inhibitors

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €181ktheir share
  • DRIMMSCoordinator

    Dissecting the role of the immune microenvironment in the onset of myelodysplastic syndromes

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €181ktheir share
  • AAVolutionPartner

    Next-generation AAV vectors for liver-directed gene therapy

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €552ktheir share
  • NONCO-MICROTISCoordinator

    Exploiting single cell long non-coding RNA biology to target therapy-induced senescence in lung cancer

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €181ktheir share
  • DESTINATIONPartner

    AI-enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells.

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €509ktheir share
  • SyLeNCeCoordinator

    Synapses between Leukaemia and its Neighbouring Cells

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €161ktheir share
  • cONCReTEPartner

    DevelOpmeNt of Cancer RNA TherapEutics

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €110ktheir share
  • LINKERCoordinator

    Elucidating transcriptional rewiring on hematological malignancies via computational methods

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €173ktheir share
  • AND-PDPartner

    COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €131ktheir share
  • CRUCIALPartner

    MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €460ktheir share
  • Tumor-Treg-TargetingPartner

    Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €248ktheir share
  • NonChroRepCoordinator

    Investigating the role of the long noncoding transcriptome in chromatin replication

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • CINKCoordinator

    Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €158ktheir share
  • EN_ACTI2NGPartner

    European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €248ktheir share
  • TARGEPILIVERCoordinator

    Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €170ktheir share
  • PROCROPCoordinator

    Professional cross-priming for ovary and prostate cancer

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €1.2Mtheir share
  • REPROPARKPartner

    New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €421ktheir share
  • INTEREXTCoordinator

    Interspecies endotheliarization for organ xenotransplantation

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €223ktheir share
  • LYMFOXP1Coordinator

    ROLE OF THE TRANSCRIPTION FACTOR FOXP1 IN B CELL FUNCTION AND LYMPHOMAGENESIS

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €230ktheir share
  • IACTPartner

    Immunostimulatory Agonist antibodies for Cancer Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €306ktheir share
  • RNATRAINPartner

    The European non-coding RNA network

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €238ktheir share
  • KRASMIRCoordinator

    The role of miRNAs in KRAS-driven Non-Small Cell Lung Cancer

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €100ktheir share
  • LINCMHEMCoordinator

    Role of DNA methylation in the regulation of lincRNAs in Hematological Malignancies

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €353ktheir share
  • FIBRO-TARGETSPartner

    Targeting cardiac fibrosis for heart failure treatment

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €600ktheir share
  • NMDAR-synprunCoordinator

    The roles of juvenile NMDA receptors in synapse maturation and elimination and their association with cognition

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €166ktheir share
  • HOMAGEPartner

    Heart OMics in AGEing

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €310ktheir share
  • BRAINVECTORSPartner

    From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV""

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €46ktheir share
  • ENDOGENOUS AEDPartner

    Supply-rate depression as endogenous anti-epileptic mechanism

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €100ktheir share
  • CANCERLINCCoordinator

    Functional and Mecahnistic Roles of Large Intergenic Non-coding RNAs in Cancer

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €1.5Mtheir share
  • EU-MASCARAPartner

    Markers for Sub-Clinical Cardiovascular Risk Assessemnt

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €314ktheir share
  • MetastasisCoordinator

    Evaluation of metastatic and angiogenic potential of cancer stem-like cells in distinct mouse models for lung and liver metastasis

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €167ktheir share
  • NAVICHEBCoordinator

    NEW ADVANCED VACCINES IN CHRONIC HEPATITIS B

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €100ktheir share
  • CURELUNGPartner

    Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €280ktheir share
  • MEDIAPartner

    The MEtabolic Road to DIAstolic Heart Failure

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €789ktheir share
  • AIPGENECoordinator

    Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €823ktheir share
Show 5 more projects
  • HEPACUTEPartner

    Host and viral factors in acute hepatitis C

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €173ktheir share
  • NEURONAL SPECIFICITYCoordinator

    Longitudinal analysis to study neurodegenerative diseases mechanisms in specific neuronal subtypes

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €100ktheir share
  • REPLACESPartner

    Restorative Plasticity At Corticostriatal Excitatory Synapses

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €344ktheir share
  • BRAINCAVPartner

    NONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAIN

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €268ktheir share
  • ENCITEPartner

    European Network for Cell Imaging and Tracking Expertise

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €264ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • alzheimer
  • anatomy and morphology
  • biomolecules
  • cardiology
  • cardiovascular diseases
  • catalysis
  • cell biology
  • cells technologies
  • cognitive neuroscience
  • colorectal cancer
  • computational science
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime